“The issue is not directly related to Rexam, but appears to be inherent in the supply chain,” Jonathan Thornton, a Rexam spokesperson, told Outsourcing-pharma.
He said “In our investigations, Rexam has identified wooden shipping pallets and transportation vessels as the primary sources for the presence of 2,4,6 Tribromophenol and its subsequent conversion to 2,4,6 Tribromoanisole.”
2,4,6 Tribromophenol is often used as a fungicide and a wood preservative, and is commonly found in wood-based products, such as wooden pallets, and on shipping and transport vessels with wooden floors, however it comes as a coincidence that both recalled Tylenol and Glumetza drugs were also manufactured in Puerto Rico.
“Our focus is and has always been on maintaining the highest standard of quality for our customers' products and assuring patient safety,” said Thornton.
“We continue to work closely with our customers and suppliers to identify all potential sources of 2,4,6 Tribromophenol in order to eliminate the risks identified,” he added.